Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Limited, an investment holding company, provides skin care products and services in Mainland China, Taiwan, and internationally. It manufactures and sells skin care, beauty, aroma-therapeutic, and make-up products, as well as health supplements under the Natural Beauty brand. The company also offers skin treatments, beauty services, medical cosmetology services, and … Read more
Natural Beauty Bio-Technology Limited (NBBTF) - Total Assets
Latest total assets as of June 2025: $851.73 Million USD
Based on the latest financial reports, Natural Beauty Bio-Technology Limited (NBBTF) holds total assets worth $851.73 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Natural Beauty Bio-Technology Limited - Total Assets Trend (2001–2024)
This chart illustrates how Natural Beauty Bio-Technology Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Natural Beauty Bio-Technology Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Natural Beauty Bio-Technology Limited's total assets of $851.73 Million consist of 37.4% current assets and 62.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 15.1% |
| Accounts Receivable | $72.20 Million | 9.3% |
| Inventory | $81.20 Million | 10.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2024)
This chart illustrates how Natural Beauty Bio-Technology Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Natural Beauty Bio-Technology Limited's current assets represent 37.4% of total assets in 2024, a decrease from 40.0% in 2001.
- Cash Position: Cash and equivalents constituted 15.1% of total assets in 2024, up from 11.8% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
- Asset Diversification: The largest asset category is inventory at 10.5% of total assets.
Natural Beauty Bio-Technology Limited Competitors by Total Assets
Key competitors of Natural Beauty Bio-Technology Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.26 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
Natural Beauty Bio-Technology Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Natural Beauty Bio-Technology Limited generates 0.46x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Natural Beauty Bio-Technology Limited is currently not profitable relative to its asset base.
Natural Beauty Bio-Technology Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.45 | 1.06 | 2.10 |
| Quick Ratio | 1.04 | 0.75 | 1.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $101.69 Million | $ 15.67 Million | $ 178.32 Million |
Natural Beauty Bio-Technology Limited - Advanced Valuation Insights
This section examines the relationship between Natural Beauty Bio-Technology Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.03 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -12.4% |
| Total Assets | $772.93 Million |
| Market Capitalization | $29.03 Million USD |
Valuation Analysis
Below Book Valuation: The market values Natural Beauty Bio-Technology Limited's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Natural Beauty Bio-Technology Limited's assets decreased by 12.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Natural Beauty Bio-Technology Limited (2001–2024)
The table below shows the annual total assets of Natural Beauty Bio-Technology Limited from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $772.93 Million | -12.42% |
| 2023-12-31 | $882.58 Million | -0.11% |
| 2022-12-31 | $883.53 Million | -5.72% |
| 2021-12-31 | $937.16 Million | +11.46% |
| 2020-12-31 | $840.77 Million | +9.46% |
| 2019-12-31 | $768.13 Million | +13.13% |
| 2018-12-31 | $678.97 Million | -12.72% |
| 2017-12-31 | $777.88 Million | -5.39% |
| 2016-12-31 | $822.19 Million | -7.47% |
| 2015-12-31 | $888.60 Million | -9.12% |
| 2014-12-31 | $977.73 Million | -0.44% |
| 2013-12-31 | $982.07 Million | +11.09% |
| 2012-12-31 | $884.06 Million | -7.78% |
| 2011-12-31 | $958.63 Million | +1.88% |
| 2010-12-31 | $940.93 Million | -5.84% |
| 2009-12-31 | $999.32 Million | -2.62% |
| 2008-12-31 | $1.03 Billion | -0.59% |
| 2007-12-31 | $1.03 Billion | +3.47% |
| 2006-12-31 | $997.66 Million | +6.42% |
| 2005-12-31 | $937.47 Million | +4.14% |
| 2004-12-31 | $900.23 Million | +6.99% |
| 2003-12-31 | $841.41 Million | -2.33% |
| 2002-12-31 | $861.49 Million | +33.05% |
| 2001-12-31 | $647.49 Million | -- |